​

Milestone Pharmaceuticals (MIST) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Milestone Pharmaceuticals Revenue Highlights

00

Milestone Pharmaceuticals Revenue by Period

Milestone Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$1.00M-80.00%
2022-12-31$5.00M-66.67%
2021-12-31$15.00M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Milestone Pharmaceuticals generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Milestone Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$108.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$-868.00K100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$1.00M-71.43%
2022-12-31$3.50M133.33%
2022-09-30$1.50M100.00%
2022-06-30-100.00%
2022-03-31--100.00%
2021-12-31$15.00M100.00%
2021-09-30--100.00%
2021-06-30$15.00M100.00%
2021-03-31--100.00%
2020-12-31$57.44M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Milestone Pharmaceuticals generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Milestone Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IPHAInnate Pharma$51.90M$16.56M
MOLNMolecular Partners$7.04M$2.74M
APLTApplied Therapeutics$455.00K$1.00M
ELTXElicio Therapeutics--
CRBPCorbus Pharmaceuticals--
SAVACassava Sciences-$840.00K
RANIRani Therapeutics--
CRDFCardiff Oncology-$121.00K
PEPGPepGen--
MISTMilestone Pharmaceuticals--

MIST Revenue FAQ

What is Milestone Pharmaceuticals’s yearly revenue?

Milestone Pharmaceuticals's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $1M, representing a decrease of -80.00% compared to 2022. MIST's yearly revenue for 2022 was $5M, representing a decrease of -66.67% compared to 2021.

What is Milestone Pharmaceuticals’s quarterly revenue?

Milestone Pharmaceuticals's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). MIST's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Milestone Pharmaceuticals’s revenue growth rate?

Milestone Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.